Connection

Thilo Jakob to Drug Resistance

Back to Details
This is a "connection" page, showing publications Thilo Jakob has written about Drug Resistance.
Thilo Jakob
Connection Strength
0.034
Drug Resistance
  1. Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial. J Allergy Clin Immunol. 2017 09; 140(3):870-873.e5.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.